Del 212 i serien Recent Results in Cancer Research

Small Molecules in Hematology

Häftad, Engelska, 2019

1 209 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib.

Produktinformation

Utgivningsdatum2019-01-10
Mått155 x 235 x 20 mm
Vikt464 g
FormatHäftad
SpråkEngelska
SerieRecent Results in Cancer Research
Antal sidor294
Upplaga3
FörlagSpringer Nature Switzerland AG
ISBN9783030082567

Tillhör följande kategorier

Onkologi inom Medicin
Hematologi inom Medicin

Uwe Martens, Prof. Dr. med., is chair of the Cancer Center Heilbronn-Franken and head of the Department of Hematology and Oncology at the SLK Clinic Heilbronn, which is an academic teaching hospital of the University of Heidelberg. He graduated in Medicine from the University of Freiburg and continued his medical and scientific training at the Medical University Center in Freiburg and at the BC Cancer Research Center in Vancouver. His scientific focus is the development of personalized cancer therapy and immunotherapy. He is a co-founder of the MOLIT Institute for Personalized Medicine at the science and technology park in Heilbronn, which aims to rapidly translate precision medicine into standard care.